Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells ; volume:9 ; number:1 ; day:1 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Scientific reports ; 9, Heft 1 (1.3.2019), 1-8, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Shi, Zhong
Yu, Xiaofu
Yuan, Meiqin
Lv, Wangxia
Feng, Tingting
Bai, Rui
Zhong, Haijun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39547-x
- URN
-
urn:nbn:de:101:1-2019032318535792967333
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shi, Zhong
- Yu, Xiaofu
- Yuan, Meiqin
- Lv, Wangxia
- Feng, Tingting
- Bai, Rui
- Zhong, Haijun
- SpringerLink (Online service)
Ähnliche Objekte (12)
LMTK3 confers chemo-resistance in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Paracrine humanin signaling promotes glioma chemoresistance
LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
CAF promotes chemoresistance through NRP2 in gastric cancer
PERK
PERK
LMTK3 confers chemo-resistance in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Paracrine humanin signaling promotes glioma chemoresistance
LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
CAF promotes chemoresistance through NRP2 in gastric cancer
PERK
PERK
LMTK3 confers chemo-resistance in breast cancer
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Paracrine humanin signaling promotes glioma chemoresistance
LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Combination of RUNX1 inhibitor and gemcitabine mitigates chemo‐resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress
Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
CAF promotes chemoresistance through NRP2 in gastric cancer
PERK